84 related articles for article (PubMed ID: 30217965)
1. Illuminating Aberrant mRNA Events in CLL.
Cancer Discov; 2018 Nov; 8(11):OF4. PubMed ID: 30217965
[TBL] [Abstract][Full Text] [Related]
2. Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia.
Lee SH; Singh I; Tisdale S; Abdel-Wahab O; Leslie CS; Mayr C
Nature; 2018 Sep; 561(7721):127-131. PubMed ID: 30150773
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Wang LQ; Chim CS
Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor genes and clonal evolution in B-CLL.
Kay NE; Ranheim EA; Peterson LC
Leuk Lymphoma; 1995 Jun; 18(1-2):41-9. PubMed ID: 8580828
[TBL] [Abstract][Full Text] [Related]
5. De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia.
Martel V; Guerci A; Humbert JC; Gregoire MJ; Chery M; Lederlin P; Jonveaux P
Br J Haematol; 1997 Nov; 99(2):320-4. PubMed ID: 9375748
[TBL] [Abstract][Full Text] [Related]
6. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
7. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling.
Hahn M; Bürckert JP; Luttenberger CA; Klebow S; Hess M; Al-Maarri M; Vogt M; Reißig S; Hallek M; Wienecke-Baldacchino A; Buch T; Muller CP; Pallasch CP; Wunderlich FT; Waisman A; Hövelmeyer N
Leukemia; 2018 Jan; 32(1):72-82. PubMed ID: 28566736
[TBL] [Abstract][Full Text] [Related]
8. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
[TBL] [Abstract][Full Text] [Related]
9. p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia.
Bromidge T; Lowe C; Prentice A; Johnson S
Br J Haematol; 2000 Oct; 111(1):223-9. PubMed ID: 11091205
[TBL] [Abstract][Full Text] [Related]
10. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.
Gaidano G; Newcomb EW; Gong JZ; Tassi V; Neri A; Cortelezzi A; Calori R; Baldini L; Dalla-Favera R
Am J Pathol; 1994 Jun; 144(6):1312-9. PubMed ID: 8203469
[TBL] [Abstract][Full Text] [Related]
11. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
12. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNA in chronic lymphocytic leukemia onset and progression.
Balatti V; Pekarky Y; Croce CM
J Hematol Oncol; 2015 Feb; 8():12. PubMed ID: 25886051
[TBL] [Abstract][Full Text] [Related]
14. B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.
Zaknoen SL; Christian SL; Suen R; Van Ness B; Kay NE
Leukemia; 1992 Jul; 6(7):675-9. PubMed ID: 1625486
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
16. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
17. Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.
Kokhaei P; Hojjat-Farsangi M; Mozaffari F; Moshfegh A; Pak F; Rashidy-Pour A; Palma M; Hansson L; Österborg A; Mellstedt H
PLoS One; 2018; 13(2):e0192839. PubMed ID: 29432497
[TBL] [Abstract][Full Text] [Related]
18. [Expression of Death Associated Protein Kinase 1 in Chronic Lymphocytic Leukemia].
Zhang GT; Liu XJ; Lu L; Zhao FY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):322-327. PubMed ID: 28446269
[TBL] [Abstract][Full Text] [Related]
19. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia.
Thompson AA; Do HN; Saxon A; Wall R
Leuk Lymphoma; 1999 Feb; 32(5-6):561-9. PubMed ID: 10048429
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional and post-transcriptional regulation of IL-1 beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia.
Rambaldi A; Bettoni S; Rossi V; Tini ML; Giudici G; Rizzo V; Bassan R; Mantovani A; Barbui T; Biondi A
Br J Haematol; 1993 Feb; 83(2):204-11. PubMed ID: 8457468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
